NASDAQ:GRPH Graphite Bio (GRPH) Stock Price, News & Analysis → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free GRPH Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$3.05▼$3.2350-Day Range$3.18▼$26.1152-Week Range$2.01▼$4.26Volume328,300 shsAverage Volume282,405 shsMarket Capitalization$185.20 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisDividendEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisDividendEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media Get Graphite Bio alerts: Email Address Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report About Graphite Bio Stock (NASDAQ:GRPH)Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. The company offers GPH102 for the treatment of beta-thalassemia; and GPH201 for the treatment of XSCID, a life-threatening disease for multiple mutations in a single gene. It also offers GPH301, a product candidate for the treatment of Gaucher disease, a genetic disorder that results in a deficiency in the glucocerebrosidase enzyme. The company was formerly known as Integral Medicines, Inc., and changed its name to Graphite Bio, Inc. in August 2020. Graphite Bio, Inc. was incorporated in 2017 and is based in South San Francisco, California.Read More Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report GRPH Stock News HeadlinesMarch 21, 2024 | finance.yahoo.comLENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate ProgressMarch 15, 2024 | finance.yahoo.comGRPH Mar 2024 5.000 putApril 23, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.March 15, 2024 | seekingalpha.comVERI, STI and VERB among mid-day moversMarch 15, 2024 | finance.yahoo.comGRPH Mar 2024 7.500 callMarch 14, 2024 | finance.yahoo.comGraphite Bio, Inc. (GRPH)March 10, 2024 | marketwatch.comGraphite Bio to Pay Special Dividend Linked to Lenz Therapeutics MergerMarch 8, 2024 | au.investing.comGraphite Bio announces $1.03 per share special dividendApril 23, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.March 8, 2024 | msn.comGraphite Bio declares special $1.03 dividendMarch 8, 2024 | businesswire.comGraphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz TherapeuticsFebruary 27, 2024 | businesswire.comGRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPHFebruary 2, 2024 | markets.businessinsider.comSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Graphite Bio, Inc. (GRPH)December 25, 2023 | seekingalpha.comGraphite Bio: Reverse Merger Leading Into Big Special Dividend And Q2 Phase 3 TrialNovember 27, 2023 | msn.comGraphite Bio (GRPH) Price Target Increased by 40.00% to 7.14November 17, 2023 | businesswire.comGRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPHNovember 17, 2023 | businesswire.comGRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPHNovember 16, 2023 | benzinga.comShareholder Alert: Ademi LLP investigates whether Graphite Bio, Inc. has obtained a Fair Price in its transaction with LENZ TherapeuticsNovember 16, 2023 | bizjournals.comShattered dream of sickle cell disease cure to end in reverse merger for Peninsula biotechNovember 16, 2023 | finance.yahoo.comWhat Makes Graphite Bio, Inc. (GRPH) a New Buy StockNovember 15, 2023 | benzinga.comGRPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Graphite Bio, Inc. Is Fair to ShareholdersNovember 15, 2023 | markets.businessinsider.comGraphite Bio To Merge With LENZ Therapeutics; Stock Down In Pre-marketNovember 15, 2023 | finance.yahoo.comLENZ Therapeutics and Graphite Bio Announce Merger AgreementNovember 9, 2023 | morningstar.comGraphite Bio Inc GRPHNovember 1, 2023 | msn.comGraphite Bio (GRPH) Price Target Increased by 25.00% to 5.10October 5, 2023 | msn.comGraphite Bio (GRPH) Price Target Increased by 11.11% to 4.08June 23, 2023 | seekingalpha.comGraphite Bio CFO resigns to pursue other opportunitiesSee More Headlines Receive GRPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Graphite Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/20/2023Ex-Dividend for 3/21 Dividend3/15/2024Dividend Payable3/21/2024Today4/23/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:GRPH CUSIPN/A CIK1815776 Webwww.graphitebio.com Phone650-484-0886FaxN/AEmployees6Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.23) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-124,650,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-33.12% Return on Assets-27.96% Debt Debt-to-Equity RatioN/A Current Ratio39.20 Quick Ratio39.20 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$3.15 per share Price / Book1.01Miscellaneous Outstanding Shares58,240,000Free Float35,874,000Market Cap$185.20 million OptionableNot Optionable Beta0.20 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesDr. Matthew Porteus M.D. (Age 58)Ph.D., Academic Founder & Director Comp: $110kStephanie YaoVice President of Communications & Investor RelationsDr. Christine Garrett P.M.P. (Age 53)Ph.D., Chief Strategy Officer Key CompetitorsGenfitNASDAQ:GNFTCompugenNASDAQ:CGENPoseida TherapeuticsNASDAQ:PSTXCandel TherapeuticsNASDAQ:CADLCentury TherapeuticsNASDAQ:IPSCView All CompetitorsInstitutional OwnershipSectoral Asset Management Inc.Bought 441,829 shares on 2/14/2024Ownership: 0.762%BML Capital Management LLCBought 447,416 shares on 2/2/2024Ownership: 0.771%BML Capital Management LLCBought 445,391 shares on 1/30/2024Ownership: 0.768%View All Institutional Transactions GRPH Stock Analysis - Frequently Asked Questions How were Graphite Bio's earnings last quarter? Graphite Bio, Inc. (NASDAQ:GRPH) announced its quarterly earnings data on Monday, March, 20th. The company reported ($3.08) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($3.43) by $0.35. How often does Graphite Bio pay dividends? What is the dividend yield for Graphite Bio? Graphite Bio declared a dividend on Friday, March 15th. Investors of record on Monday, March 18th will be given a dividend of $7.21 per share on Thursday, March 21st. This represents a dividend yield of 28.93%. The ex-dividend date is Friday, March 15th. Read our dividend analysis for GRPH. When did Graphite Bio's stock split? Graphite Bio shares reverse split on Friday, March 22nd 2024. The 1-7 reverse split was announced on Friday, March 22nd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, March 22nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split. When did Graphite Bio IPO? Graphite Bio (GRPH) raised $224 million in an initial public offering on Friday, June 25th 2021. The company issued 14,000,000 shares at $15.00-$17.00 per share. This page (NASDAQ:GRPH) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeHow to camouflage a factory of 53,000 workersStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Graphite Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
